
QBench provides a comprehensive solution for monitoring all your samples and their positions within the workflow through a unified platform. By using QBench, you can forgo the traditional reliance on spreadsheets, shared network folders, and outdated paper tracking systems. The platform enables you to review numerous PDF reports and Certificates of Analysis (COAs) before finalizing or distributing them via email. You also have the option to create customizable barcodes and labels for your samples, ensuring compatibility with standard printers and scanners. Additionally, QBench features a billing module that streamlines the creation and dispatch of invoices directly from the system. Users can access data on counts and latencies for various data types within QBench, which encompasses metrics such as turnaround times, sample counts per test, delays, and more. This innovative tool simplifies the data collection process necessary for the assays conducted in your laboratory while enhancing overall efficiency. With QBench, managing your laboratory workflow has never been more straightforward and effective.
Learn more
SciSure is revolutionizing laboratories across the globe with innovative digital solutions designed for the future. Our Digital Lab Platform (DLP) integrates essential tools such as Electronic Lab Notebooks (ELN) and Laboratory Information Management Systems (LIMS), alongside cutting-edge technologies like artificial intelligence and machine learning. Engineered for effortless integration with your laboratory's existing hardware and software, this platform significantly boosts flexibility, security, and overall efficiency. By streamlining and optimizing your research and development processes within a secure and compliant framework, we enable researchers to focus more on driving innovation. Our dedicated team of experts is here to assist you throughout every phase of your digital lab transformation journey, ensuring a smooth transition.
Learn more
SciSpace BioMed Agent
SciSpace BioMed operates as a cutting-edge AI-driven "co-scientist" specifically designed for biomedical research, merging a vast collection of literature with an array of over 150 bio-tools and more than 100 academic databases and software applications to streamline complex research activities that span genomics, single-cell analysis, drug discovery, and clinical genomics. It enables researchers to interact using natural language, manage datasets, analyze genetic variants or multi-omics data, structure experimental workflows, reason through clinical biology and diseases, and create publication-ready outputs like figures, tables, and presentations while maintaining transparency and proper citation practices. Additionally, the platform features a “chat with PDF” option, allowing users to engage directly with scientific articles by highlighting text and seeking clarification on challenging material, thus serving as a valuable resource for understanding intricate methods and concepts. Moreover, for conducting literature reviews or initiating research, its AI-optimized semantic search can navigate millions of academic papers, yielding citation-supported summaries that foster a deeper comprehension of the relevant literature. This powerful functionality not only expedites the research journey but also empowers scientists to dedicate more time to their innovative discoveries rather than getting bogged down by administrative responsibilities, enhancing overall productivity in the field. Ultimately, SciSpace BioMed represents a significant advancement in how researchers approach complex biomedical inquiries, offering tools that make the research process both efficient and insightful.
Learn more
Recursion
Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.
Learn more